Biochemical Hepatic Changes in Chronic Hepatitis C Patients Induced by Sofosbuvir and Daclatasvir with or without Ribavirin Regimens

Hepatitis C Virus Clearance with Sofosbuvir / Daclatasvir Regime Improves Oxidative Stress of Diabetic Status in HCV Patients by Regulating NF-κB / Nrf2 mRNA expression

The relation between interleukin 28B gene polymorphisms (rs8099917 and rs12980275) and the response of treatment of Hepatitis C Virus genotype 4 patients to Sofosbuvir and Daclat

Efficacy of Sofosbuvir-Daclatasvir in Treatment of Chronic Hepatitis C Virus Infection

Study the Effect of Sofosbuvir, Daclatasvir and Ribavirin on Hematologic Profile, ‎Vitamin B12 and Folic Acid Levels in HCV-Related Cirrhotic Patients‎

Direct Acting Antivirals Impact on Biochemical, Immunological and Hematological Responses in HCV Infected Patients

Do Sofosbuvir and Daclatasvir Affect Vitamin D and Iron Status in Chronic Hepatitis C Virus Patients? Role of Hepcidin

Efficacy and Adverse Effects of Sofosbuvir-Based Therapies (Double and Triple Regimens) in Chronic HCV Patients

Impact of Treatment of Chronic HCV Patients by Direct Acting Antiviral Drugs (DAADs) on COVID -19 Disease Frequency and Severity

Impact of Sustained Virological Response on ‎Metabolic Changes and Vitamin-D Status in ‎Patients with Hepatitis C Viral Infection Treated by ‎Direct Acting Antiviral drugs